Literature DB >> 24101124

Sarcopenia and chemotherapy dosing in obese patients.

Alessandro Laviano1, Serena Rianda, Filippo Rossi Fanelli.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24101124     DOI： 10.1038/nrclinonc.2013.108-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  12 in total

Review 1.  Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

Authors:  Jennifer J Griggs; Pamela B Mangu; Holly Anderson; Edward P Balaban; James J Dignam; William M Hryniuk; Vicki A Morrison; T May Pini; Carolyn D Runowicz; Gary L Rosner; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Gary H Lyman
Journal:  J Clin Oncol       Date:  2012-04-02       Impact factor: 44.544

Review 2.  Sarcopenic obesity: A Critical appraisal of the current evidence.

Authors:  C M M Prado; J C K Wells; S R Smith; B C M Stephan; M Siervo
Journal:  Clin Nutr       Date:  2012-07-17       Impact factor: 7.324

Review 3.  Chemotherapy dosing in overweight and obese patients with cancer.

Authors:  Gary H Lyman; Alex Sparreboom
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

Review 4.  Body composition phenotypes in pathways to obesity and the metabolic syndrome.

Authors:  A G Dulloo; J Jacquet; G Solinas; J-P Montani; Y Schutz
Journal:  Int J Obes (Lond)       Date:  2010-12       Impact factor: 5.095

Review 5.  Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.

Authors:  Alessandro Laviano; Michael M Meguid; Akio Inui; Maurizio Muscaritoli; Filippo Rossi-Fanelli
Journal:  Nat Clin Pract Oncol       Date:  2005-03

6.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

7.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

Review 8.  Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses.

Authors:  Vickie Baracos; Seyyed Mohammad Reza Kazemi-Bajestani
Journal:  Int J Biochem Cell Biol       Date:  2013-06-29       Impact factor: 5.085

9.  American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.

Authors:  Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn
Journal:  J Clin Oncol       Date:  2012-02-06       Impact factor: 44.544

10.  Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma.

Authors:  Olivier Mir; Romain Coriat; Benoit Blanchet; Jean-Philippe Durand; Pascaline Boudou-Rouquette; Judith Michels; Stanislas Ropert; Michel Vidal; Stanislas Pol; Stanislas Chaussade; François Goldwasser
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240
View more
  2 in total

1.  Appropriate chemotherapy dosing in obese patients with cancer.

Authors:  Gary H Lyman; Alex Sparreboom
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

2.  ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker.

Authors:  Mitja Lainscak; Alessandro Laviano
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-08-05       Impact factor: 12.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.